Ps: Not sure how it’s all going to work if CDx goes ahead with Janssen, but this is a recent CDx for a bladder Ca treatment (Janssen), developed by QIAGEN and is available through LabCorp, a tier one USA lab, that also owns Covance (Global clinical trials laboratory provider):
https://www.businesswire.com/news/home/20190510005248/en/LabCorp-Announces-Availability-New-QIAGEN-therascreen-FGFR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.020(6.56%) |
Mkt cap ! $49.05M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.5¢ | $175.8K | 590.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 88240 | 4 |
View Market Depth
| Last trade - 15.08pm 26/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |